Insights
Tracking Post-COVID Conditions to Uncover Prevalence and Affected Populations
Nearly all of us remember getting sick with COVID. But most of us don’t know how many people suffered well after their acute COVID symptoms had resolved.
December 10, 2025
Chronic DiseaseHealth IT
Nearly all of us remember getting sick with COVID. But most of us don’t know how many people suffered well after their acute COVID symptoms had resolved.
The Centers for Disease Control and Prevention contracted with Comagine Health to evaluate patient data to quantify the appearance of new and persistent health conditions following a positive COVID test, called post-COVID conditions (PCCs) or long COVID. In the Tracking the Burden, Distribution and Impact of Post COVID-19 Conditions in Diverse Populations for Children Adolescents and Adults study, we looked at PCCs showing up in the year after COVID using health information exchange databases that collect clinical data for a state or a region within a state.
Comagine Health analyzed data on roughly 39,000 adults with COVID between April 2022 and October 2024 in Bronx County, New York, and roughly 16,000 adults with COVID between April 2022 and January 2025 in Utah.
We only looked at patients who had at least one provider visit in the year before they got COVID to be sure to catch and distinguish problems present before the COVID infection from PCCs.
We found that across all adults with COVID, about 60% had at least one PCC in the year after their COVID infection. Incidence was lowest among those age 18-24 (40%) and highest in those age 75-84 (70%). Across all adults, about 62% of females with COVID had PCCs compared to about 58% of males. PCC burden decreased with time.
The greater the number of pre-COVID problems, the greater the number of PCCs. About 45% of patients without pre-COVID problems had PCCs, gradually increasing to 84% of patients with five or more pre-COVID problems. People who were hospitalized with acute COVID were more likely to get PCCs (70%) than people who were not hospitalized (59%).
Social vulnerability, including poverty, crowded housing, lack of vehicle access and more, was associated with a higher chance of PCCs in the Bronx: 45% of people with low or medium vulnerability got PCCs, increasing to 62% of people with high vulnerability. PCCs were not correlated with race or ethnicity.
The most common post-COVID problems, or new medical conditions associated with the initial COVID infection, were neuro-psychiatric, including headache, anxiety, mood disorders, sleep disorders and cognitive disorders (including “brain fog”). Next most common were musculoskeletal pain and disorders. Respiratory problems were third most common, and included cough, asthma and shortness of breath. These were followed by cardiovascular problems including hypertension, heart attack, stroke, rhythm disturbances and congestive heart failure.
Our study did not characterize how debilitated people were by their post-COVID conditions or how pre-existing problems got worse after COVID. The symptoms had to be bad enough for people to visit their providers and for their providers to list the problems on their medical chart and bill, so this quantification of PCC may be an undercount. Although the number of problems tended to diminish in the year after COVID, the study did not assess how many patients were still suffering more than a year after their COVID infection. Finally, the study did not look at treatments for post-COVID conditions.
Even with these limitations, the findings are important for several reasons. Understanding the burden of PCCs will inform future pandemic planning efforts and increase providers’ understanding of PCCs for better patient care. Understanding risk and protective factors for future development of PCCs, or post-viral conditions for COVID-like illnesses in the future, will guide prevention efforts.
Author / Contributor(s)
Recent Insights